HomeMETX • CNSX
add
ME Therapeutics Holdings Inc
Previous close
$4.80
Year range
$0.75 - $11.00
Market cap
142.03M CAD
Avg Volume
426.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | May 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 360.63K | -32.87% |
Net income | -353.45K | 28.74% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -349.04K | 35.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | May 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.71M | 3.30% |
Total assets | 2.01M | 20.49% |
Total liabilities | 172.07K | 268.07% |
Total equity | 1.84M | — |
Shares outstanding | 29.59M | — |
Price to book | 80.00 | — |
Return on assets | -41.42% | — |
Return on capital | -42.73% | — |
Cash Flow
Net change in cash
| (CAD) | May 2025info | Y/Y change |
|---|---|---|
Net income | -353.45K | 28.74% |
Cash from operations | -264.49K | -84.98% |
Cash from investing | -66.20K | — |
Cash from financing | -16.34K | -103.63% |
Net change in cash | -347.02K | -213.03% |
Free cash flow | -150.52K | — |
About
Founded
2014
Headquarters
Website
